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Figure S-1. Structure of compound 20 in the solid state in two different orientations (cineromycin 
numbering scheme); all hydrogen atoms are omitted for clarity 
CCDC 1048778 contains the supporting crystallographic data for this paper. These data can be 
obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
X-ray Crystal Structure Analysis of Compound 20. X-ray Crystal Structure Analysis of 8977: C16 H24 
O4, Mr = 280.35  g · mol
-1, colorless plate, crystal size 0.30 x 0.12 x 0.03 mm, orthorhombic, space 
group P212121, a =  7.2789(9) Å, b = 10.7001(13) Å, c = 19.387(2) Å, V = 1510.0(3) Å
3, T = 100 K, Z = 4, 
Dcalc = 1.233  g·cm
3,  = 1.54178 Å, (Cu-K) = 0.707 mm-1, Empirical absorption correction (Tmin = 
0.37, Tmax = 0.69), Bruker-AXS Proteum X8 diffractometer,  4.561 <  < 55.082°, 17540 measured 
reflections, 1896  independent reflections, 1741 reflections with I > 2 (I), Structure solved by direct 
methods and refined by full-matrix least-squares against F2 to R1 = 0.034 [I > 2(I)], wR2 =  0.084, 186 
parameters, absolute structure parameter = 0.01(13), H atoms riding,  extinction coefficient = 
0.0054(8), S =  1.042, residual electron density 0.2 / 0.2 e Å-3.  
Preparative Results 
General. All reactions were carried out under Ar in flame-dried glassware. The solvents were purified 
by distillation over the drying agents indicated and were transferred under Ar: THF, Et2O 
(Mg/anthracene), CH2Cl2, MeCN (CaH2), toluene, benzene (Na/K), MeOH (Mg). DMF and NEt3 were 
dried by an absorption solvent purification system based on molecular sieves. DBU, TMEDA and 
pyridine were purified by distillation over CaH2 and transferred under Ar. Flash chromatography: 
Merck silica gel 60 (40–63 μm). NMR: Spectra were recorded on a Bruker AV 400 spectrometer in the 
solvents indicated; chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. 
The solvent signals were used as references and the chemical shifts converted to the TMS scale 
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(CDCl3: δC ≡ 77.16 ppm; residual CHCl3 in CDCl3: δH ≡ 7.26 ppm) For clarity, Sn–H couplings of the 
vinylic protons were omitted in the multiplet analysis but are given in brackets. 119Sn NMR spectra 
were recorded on a Bruker AV VIII 300 spectrometer using Me4Sn as external standard. IR: Spectrum 
One (Perkin-Elmer) spectrometer, wavenumbers (𝑣)̃ in cm-1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-
MS: ESQ 3000 (Bruker), accurate mass determinations: Bruker APEX III FT-MS (7 T magnet) or MAT 95 
(Finnigan). Unless stated otherwise, all commercially available compounds (ABCR, Acros, Aldrich, 
Strem) were used as received; CuTC was purchased from Aldrich. Zn(OTf)2 was dried at 120 °C at 
1x10-2 mbar for 12 h. [Cp*RuCl2]n
 1 and [(Ph3SiO)4MoCPh]K
 (21)2 were prepared according to 
literature procedures and were stored under Argon. Commercial Bu3SnH is stabilized with 0.05% of 
3,5-di-tert-butyl-4-hydroxytoluene, which was not removed in the reactions described herein. 
(S)-4-Methylhex-5-enoic acid (5). Ozone was bubbled through a solution of (S)-citronellene (4) (14.6 
g, 105 mmol) in CH2Cl2 (600 mL) at ‒78 °C for 3.5 h. The progress of the reaction was 
carefully monitored by TLC. Once the substrate was consumed, the mixture was treated 
with Me2S (40 mL, 540 mmol) and allowed to warm to room temperature. The solution was 
washed with water and brine and dried over MgSO4, the drying agent was filtered off and 
the solvent evaporated. The crude aldehyde was dissolved in tBuOH/water (2:1, 525 mL) and 
NaH2PO4 (38.0 g, 316 mmol) and H2O2 (30% w/w in water, 62 mL, 546 mmol) were successively 
introduced. The mixture was cooled to 0 °C before NaClO2 (57.4 g, 634 mmol) was added in portions. 
The ice bath was removed and stirring continued for 21 h. For work up, the mixture was extracted 
with Et2O and the combined organic phases were repeatedly extracted with sat. aq. NaHCO3. The 
combined aqueous layers were carefully acidified with aq. HCl (2 M) and then extracted with Et2O (3 
x). The combined organic layers were washed with brine and dried over MgSO4, the drying agent was 
filtered off and the solvent was evaporated. Purification of the residue by flash chromatography 
(silica, hexanes/tert-butyl methyl ether, 2:1) afforded the title compound as a colorless oil (10.9 g, 
80%). [𝑎]𝐷
20: +10.2 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 11.55 – 9.00 (bs, 1H), 5.63 (ddd, J = 
17.5, 10, 7.5 Hz, 1H), 5.05 – 4.92 (m, 2H), 2.40 – 2.30 (m, 2H), 2.16 (hex., J = 7.0 Hz, 1H), 1.76 – 1.53 
(m, 2H), 1.02 ppm (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 179.0, 142.4, 113.0, 36.6, 31.0, 
30.2, 19.3 ppm. IR (film): ?̃? = 3079, 2962, 2929, 2871, 2672, 1715, 1455, 1416, 1376, 1276, 914 cm-1; 
HR (EI): m/z calcd. for [C7H11O2
]: 127.0765; found 127.0764. 
(5S,6S)-6-(Iodomethyl)-5-methyltetrahydro-2H-pyran-2-one (S-1). Iodine (19.3 g, 76.1 mmol) was 
added in one portion to a solution of acid 5 (3.25 g, 25.4 mmol) in CH3CN (81 mL). The dark 
red mixture was stirred at room temperature for 3 h before it was diluted with tert-butyl 
methyl ether. The reaction was quenched with sat. aq. Na2S2O3, the layers were separated 
and the aqueous layer was extracted with tert-butyl methyl ether. The combined extracts 
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were dried over MgSO4, the drying agent was filtered off and the solvent was evaporated. 
Purification of the residue (d.r.: 7.5:1, NMR) by flash chromatography (silica, hexanes/Et2O, 1:1) 
afforded the title compound as a diastereomerically pure white solid (4.73 g, 73%). Mp = 70-72 
°C. [𝑎]𝐷
20: ‒10.5 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 3.64 (dt, J = 9.3, 3.4 Hz, 1H), 3.53 (dd, J = 
11.4, 3.0 Hz, 1H), 3.38 (dd, J = 11.4, 3.8 Hz, 1H), 2.65 (ddd, J = 18.1, 6.4, 3.3 Hz, 1H), 2.53 (ddd, J = 
17.9, 6.8, 11.1 Hz, 1H), 1.99 – 1.87 (m, 2H), 1.74 – 1.61 (m, 1H), 1.01 ppm (d, J = 6.3 Hz, 3H). 13C NMR 
(101 MHz, CDCl3): δ = 170.5, 82.8, 33.6, 29.9, 27.2, 17.0, 9.0 ppm. IR (film): ?̃? = 2963, 2937, 2876, 
1735, 1461, 1416, 1342, 1291, 1249, 1227, 1177, 1101, 1038, 1006 cm-1 HR-ESI: m/z calcd. for 
[C7H11IO2Na]
+: 276.9696; found 276.9696. 
(5S,6R)-5,6-Dimethyltetrahydro-2H-pyran-2-one (6). Tributylstannane (5.90 mL, 21.9 mmol) was 
added to a solution of compound S-1 (3.70 g, 14.6 mmol) in benzene (35 mL) and the 
resulting mixture was stirred at reflux temperature for 2 h. The mixture was allowed to cool 
before the reaction was quenched with sat. aq. KF. The resulting mixture was stirred for 30 
min and then diluted with water. After extraction of the aqueous layer with tert-butyl 
methyl ether, the combined extracts were washed with brine and dried over MgSO4. The drying 
agent was filtered off and the solvent was evaporated. Purification of the residue by flash 
chromatography (silica, hexanes/Et2O, 4:1 to 1:1) afforded the title compound as a colorless oil (1.64 
g, 88%). [𝑎]𝐷
20: +26.0 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.01 (dq, J = 9.6, 6.3 Hz, 1H), 2.58 
(ddd, J = 17.9, 4.2 Hz, 1H), 2.43 (ddd, J = 17.6, 7.4, 10.2 Hz, 1H), 1.94 – 1.83 (m, 1H), 1.69 – 1.48 (m, 
2H), 1.31 (d, J = 6.3 Hz, 3H), 0.96 ppm (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 171.8, 82.5, 
34.6, 29.7, 27.8, 20.0, 17.3 ppm. IR (film): ?̃? = 2977, 2937, 2880, 2251, 1726, 1461, 1338, 1351, 1225, 
1094, 1045, 912, 727 cm-1. HR-ESI: m/z calcd. for [C7H12O2Na]
+: 151.0730; found 151.0729. 
(2R,3S)-3-Methyloct-6-yn-2-ol (8). CCl4 (47.8 mL, 495 mmol) was added dropwise over 4 h to a 
refluxing solution of lactone 6 (1.40 g, 10.9 mmol) and PPh3 (13.19 g, 50.3 mmol) in THF 
(220 mL). Once the addition was complete, the reaction was quenched with water and the 
mixture extracted with tert-butyl methyl ether. The combined extracts were washed with 
brine and dried over MgSO4, the drying agent was filtered off and the solution was 
concentrated to a volume of ca. 10 mL. Pentane was added and the precipitated solid was filtered 
off. After repeating this operation 3 times, the solvent was evaporated and the residue was purified 
by flash chromatography (silica, pentane). Because of its limited stability, the resulting product 7 was 
immediately used in the next step without characterization. 
MeLi (1.6 M in Et2O, 20.4 mL, 32.6 mmol) was added dropwise to a solution of the dichloroolefin 7 
(2.12 mg, 10.9 mmol) and Cu(acac)2 (285 mg, 1.09 mmol, 10 mol%) in Et2O (76 mL) at 0 °C. The 
mixture was stirred for 14 h at room temperature before the reaction was quenched with sat. aq. 
NH4Cl. The aqueous layer was extracted with tert-butyl methyl ether, the combined extracts were 
washed with brine and dried over MgSO4, the drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (silica, pentane/Et2O, 4:1 to 1:1) 
afforded the title compound as a colorless oil (1.13 g, 74%). [𝑎]𝐷
20: ‒4.6 (c = 1, CHCl3). 
1H NMR (400 
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MHz, CDCl3): δ = 3.73 – 3.62 (m, 1H), 2.31 – 2.17 (m, 1H), 2.17 – 2.03 (m, 1H), 1.76 (t, J = 2.6 Hz, 3H), 
1.72 – 1.55 (m, 2H), 1.47 – 1.40 (bs, 1H), 1.36 – 1.22 (m, 1H), 1.13 (t, J = 6.3 Hz, 3 H), 0.87 ppm (d, J = 
6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 79.2, 75.8, 71.6, 39.2, 31.9, 19.6, 16.6, 14.4, 3.6 ppm. IR 
(film): ?̃? = 3378, 2968, 2920, 2876, 2454, 1378, 1320, 1092, 1058, 1005, 922 cm-1; HR (EI): m/z calcd. 
for [C9H16O]: 140.11200; found 140.12012.  
(R)-((3,7-Dimethylocta-1,6-dien-3-yl)oxy)triethylsilane (S-2). Et3SiCl (5.6 mL, 33.5 mmol) was added 
dropwise to a solution of (R)-linalool (4.0 mL, 22.3 mmol), imidazole (3.0 g, 44.6 mmol) 
and DMAP (1.1 mmol, 0.14 g) in CH2Cl2 (40 mL). The mixture was stirred for 15 h before 
the reaction was quenched with sat. aq. NaHCO3. The organic phase was extracted 
with CH2Cl2, the combined extracts were dried over MgSO4, the drying agent was 
filtered off and the solvent was evaporated. Purification of the residue by flash chromatography 
(silica, hexanes) afforded the title compound as a colorless oil (5.9 g, 99%). [𝑎]𝐷
20: –5.2 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.85 (dd, J = 17.3, 10.6 Hz, 1H), 5.14 (dd, J = 17.3, 1.7 Hz, 1H), 5.09 
(ddt, J = 8.7, 5.9, 1.5 Hz, 1H), 4.99 (dd, J = 10.7, 1.7 Hz, 1H), 2.09 – 1.89 (m, 2H), 1.67 (d, J = 1.4 Hz, 
3H), 1.59 (s, 3H), 1.54 – 1.41 (m, 2H), 1.29 (s, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.58 ppm (q, J = 7.8 Hz, 6H). 
13C NMR (101 MHz, CDCl3): δ = 145.6, 131.3, 124.9, 111.8, 75.5, 43.9, 27.5, 25.9, 23.0, 17.7, 7.3, 6.9 
ppm. IR (film): ?̃? = 2955, 2913, 2876, 1457, 1413, 1370, 1238, 1175, 1118, 1047, 1003 cm-1. HR-ESI: 
calcd. for [C16H32OSiNa]
+: 291.21146; found 291.21139. 
(R)-4-Methyl-4-((triethylsilyl)oxy)hex-5-enal (10). Ozone was bubbled through a solution of the silyl 
ether S-2 (5.8 g, 21.6 mmol) and pyridine (2.1 mL, 25.9 mmol) in CH2Cl2 (100 mL) at –78 
°C for 2 h. The progress of the reaction was carefully monitored by TLC. Upon 
completion, the reaction mixture was filtered through a pad of Celite® into ice water 
(170 mL) containing Me2S (3.5 mL, 47.88 mmol). The resulting mixture was warmed to 
room temperature and stirred for additional 2 h. The layers were separated and the aq. phase was 
extracted with CH2Cl2. The combined extracts were dried over MgSO4, the drying agent was filtered 
off and the solvent was evaporated. Purification of the residue by flash chromatography (silica, 
hexanes/EtOAc, 30:1) afforded the title compound as a colorless oil (4.0 g, 77%). [𝑎]𝐷
20: +2.5 (c = 1, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 9.75 (t, J = 1.8 Hz, 1H), 5.79 (dd, J = 17.3, 10.7 Hz, 1H), 5.16 (dd, 
J = 17.3, 1.5 Hz, 1H), 5.04 (dd, J = 10.6, 1.5 Hz, 1H), 2.57 – 2.36 (m, 2H), 1.90 - 1.73 (m, 2H), 1.34 (s, 
3H), 0.94 (t, J = 7.9 Hz, 9H), 0.58 ppm (q, J = 7.6 Hz, 6H). 13C NMR (101 MHz, CDCl3): δ = 203.2, 144.6, 
112.9, 74.8, 39.3, 36.0, 27.7, 7.2, 6.8 ppm. IR (film): ?̃? = 2955, 2912, 2876, 2716, 1726, 1458, 1413, 
1372, 1237, 1178, 1125, 1042, 1005 cm-1 HR-ESI: m/z calcd. for [C13H26O2SiNa]
+: 265.15943; found 
265.15935. 
(4S,7R)-7-Methyl-7-((triethylsilyl)oxy)non-8-en-2-yn-4-ol (S-3). Triethylamine (4.7 mL, 33.6 mmol,) 
was added dropwise to a suspension of Zn(OTf)2 (11.64 g, 32.0 mmol) and 
()-N-methylephedrine (6.03 g, 33.6 mmol) in toluene (110 mL) at room 
temperature. After stirring for 2 h, liquid propyne (ca. 10 mL) was added via 
cannula from a Schlenk tube at –78 °C and the resulting mixture was stirred for 45 
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min at room temperature. Next, a solution of aldehyde 10 (3.88 g, 16.0 mmol) in toluene (16 mL) was 
added dropwise over 5 h. Once the addition was complete, the mixture was stirred for 12 h before 
the reaction was quenched with sat. aq. NH4Cl. The aqueous phase was extracted with Et2O, the 
combined extracts were dried over MgSO4, the drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (silica, hexanes/EtOAc, 10:1) 
afforded the title compound as a colorless oil (4.26 g, 94%). [𝑎]𝐷
20: –3.2 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 5.85 (dd, J = 17.3, 10.7 Hz, 1H), 5.15 (dd, J = 17.3, 1.5 Hz, 1H), 5.01 (dd, J = 10.6, 1.5 
Hz, 1H), 4.38 – 4.29 (m, 1H), 2.17 (d, J = 5.1 Hz, 1H), 1.83 (d, J = 2.1 Hz, 3H), 1.80 – 1.68 (m, 2H), 1.68 
– 1.61 (m, 2H), 1.33 (s, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.60 ppm (q, J = 7.7 Hz, 6H). 13C NMR (101 MHz, 
CDCl3): δ = 145.2, 112.3, 80.9, 80.6, 75.4, 63.0, 39.2, 32.9, 27.5, 7.2, 6.8, 3.7 ppm; IR (film): ?̃? = 3382, 
2954, 2914, 2876, 1458, 1413, 1370, 1304, 1237, 1179, 1115, 1048, 1004; HR-ESI: m/z calcd. for 
[C16H30O2SiNa]
+: 305.19073; found 305.19055.  
(5S,8R)-10,10-Diethyl-2,2,3,3,8-pentamethyl-5-(prop-1-yn-1-yl)-8-vinyl-4,9-dioxa-3,10-disila-
dodecane (11). tert-Butyldimethylchlorosilane (2.50 g, 16.6 mmol) was added in 
one portion to a solution of alcohol S-3 (4.26 g, 15.1 mmol) and imidazole (1.23 g, 
18.1 mmol) in CH2Cl2 (30 mL). The mixture was stirred for 20 h before the reaction 
was quenched with sat. aq. NaHCO3. The aqueous layer was extracted with 
CH2Cl2, the combined extracts were dried over MgSO4, the drying agent was filtered off and the 
solvent was evaporated. Purification of the residue by flash chromatography (silica, hexanes/EtOAc, 
50:1) afforded the title compound as a colorless oil (5.98 g, quant.). [𝑎]𝐷
20: –28.1 (c = 1, CHCl3). 
1H 
NMR (400 MHz, CDCl3): δ = 5.82 (dd, J = 17.2, 10.6 Hz, 1H), 5.14 (dd, J = 17.3, 1.7 Hz, 1H), 4.98 (dd, J = 
10.6, 1.7 Hz, 1H), 4.34 – 4.26 (m, 1H), 1.81 (d, J = 2.1 Hz, 3H), 1.74 –1.52 (m, 4H), 1.30 (s, 3H), 0.94 (t, 
J = 7.9 Hz, 9H), 0.89 (s, 9H), 0.58 (q, J = 7.9 Hz, 6H), 0.11 (s, 3H), 0.08 ppm (s, 3H). 13C NMR (101 MHz, 
CDCl3): δ = 145.5, 111.9, 81.1, 80.0, 75.3, 63.6, 39.1, 33.8, 27.9, 26.0, 18.4, 7.3, 6.9, 3.7, 4.4, 4.9 
ppm. IR (film): ?̃? = 2955, 2930, 2877, 2857, 1461, 1413, 1362, 1250, 1180, 1083, 1058, 1004 cm-1. HR-
ESI: m/z calcd. for [C22H44O2Si2Na]
+: 419.27721; found 419.27696.  
(2R,5S)-5-((tert-Butyldimethylsilyl)oxy)-2-methyl-2-((triethylsilyl)oxy)oct-6-ynal (S-4). Ozone was 
bubbled through a solution of compound 11 (5.63 g, 14.2 mmol) in CH2Cl2 (140 mL) 
at ‒78 °C. The progress of the reaction was carefully monitored by TLC. Once the 
conversion was complete (ca. 1 h), Me2S (5 mL, 67.6 mmol) was added and the 
resulting mixture stirred for 1 h at –78 °C and for 2 h at room temperature. Water 
was introduced and the mixture extracted with CH2Cl2. The combined extracts were dried over 
MgSO4, the drying agent was filtered off and the solvent was evaporated. Purification of the residue 
by flash chromatography (silica, hexanes/EtOAc, 50:1) afforded the title compound as a colorless oil 
(3.80 g, 67%). [𝑎]𝐷
20: –9.1 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 9.55 (s, 1H), 4.36 – 4.25 (m, 
1H), 1.81 (d, J = 2.1 Hz, 3H), 1.77 – 1.63 (m, 3H), 1.63 – 1.52 (m, 1H), 1.27 (s, 3H), 0.96 (t, J = 7.9 Hz, 
9H), 0.89 (s, 9H), 0.61 (q, J = 7.9 Hz, 6H), 0.10 (s, 3H), 0.08 ppm (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 
205.0, 80.6, 80.4, 80.1, 63.1, 34.6, 32.7, 26.0, 23.0, 18.4, 7.1, 6.7, 3.7, 4.4, 4.9 ppm. IR (film), ?̃? = 
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2955, 2931, 2878, 2858, 1738, 1461, 1414, 1362, 1250, 1193, 1084, 1058, 1006 cm-1; HR-ESI: calcd. 
for [C21H42O3Si2Na]
+: 421.25647; found 421.25651. 
(4R,7S,E)-7-((tert-Butyldimethylsilyl)oxy)-4-methyl-4-((triethylsilyl)oxy)dec-2-en-8-ynoic acid (12). 
Diethylphosphonoacetic acid (1.48 mL, 9.2 mmol), TMEDA (1.50 mL, 10.0 mmol) 
and DBU (5.00 mL, 33.4 mmol) were added to a suspension of Zn(OTf)2 (6.68 g, 
18.4 mmol) in THF (25 mL) at 0 °C. Aldehyde S-4 (3.31 g, 8.35 mmol) was 
introduced, the ice-bath was removed and the mixture stirred for 16 h at room 
temperature. The reaction was quenched with saturated aq. NH4Cl and the 
aqueous layer extracted with CH2Cl2 (4 x) The combined extracts were washed with brine, which was 
re-extracted with CH2Cl2 (4 x). The combined extracts were dried over MgSO4, the drying agent was 
filtered off and the solution was concentrated. Purification of the crude product by flash 
chromatography (silica, hexane/EtOAc, 5:1 to 2:1 to 1:1) afforded the title compound as a colorless 
oil (2.95 g, 80%). [𝑎]𝐷
20: 19.4 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 11.88 – 10.48 (bs, 1H), 
6.97 (d, J = 15.4 Hz, 1H), 5.98 (d, J = 15.4 Hz, 1H), 4.37 – 4.24 (m, 1H), 1.81 (d, J = 2.1 Hz, 3H), 1.79 – 
1.60 (m, 3H), 1.58 – 1.48 (m, 1H), 1.38 (s, 3H), 0.96 (t, J = 7.9 Hz, 9H), 0.89 (s, 9H), 0.62 (q, J = 7.8 Hz, 
6H), 0.10 (s, 3H), 0.08 ppm (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 171.6, 157.7, 118.1, 80.8, 80.3, 
75.1, 63.1, 38.4, 33.4, 28.2, 25.9, 18.4, 7.2, 6.8, 3.6, –4.5, –4.9 ppm. IR (film) ?̃? = 2955, 2930, 2877, 
2857, 2688, 1697, 1654, 1461, 1415, 1303, 1249, 1162, 1083, 1056, 1004 cm-1. HR-ESI: m/z calcd. for 
[C23H43O4Si2]
-: 439.27054; found 439.27079.  
(2R,3S)-3-Methyloct-6-yn-2-yl (4R,7S,E)-7-((tert-butyldimethylsilyl)oxy)-4-methyl-4-((triethylsilyl)-
oxy)dec-2-en-8-ynoate (13). DCC (1.16 g, 5.60 mmol) was added in one portion 
to a solution of alcohol 8 (635 mg, 4.53 mmol), acid 12 (1.90 g, 4.31 mmol) and 
DMAP (53 mg, 0.43 mmol) in CH2Cl2 (30 mL) at 0 °C. After stirring for 30 min, the 
mixture was filtered through a plug of Celite® and the filtrate was concentrated. 
Purification of the residue by flash chromatography (silica, hexanes/EtOAc, 40:1 
to 30:1) afforded the title compound as a colorless oil (2.04 g, 84%). [𝑎]𝐷
20: ‒13.4 (c = 1, CH3OH). 
1H 
NMR (400 MHz, CDCl3) δ = 6.83 (d, J = 15.5 Hz, 1H), 5.91 (d, J = 15.5 Hz, 1H), 4.88 (p, J = 6.3 Hz, 1H), 
4.30 (ddt, J = 5.6, 3.7, 2.1 Hz, 1H), 2.29 – 2.15 (m, 1H), 2.10 (dtq, J = 13.6, 8.0, 2.5 Hz, 1H), 1.86 – 1.79 
(m, 1H), 1.81 (d, J = 2.1 Hz, 3H), 1.77 (t, J = 2.5 Hz, 3H), 1.75 –1.61 (m, 4H), 1.59 – 1.49 (m, 1H), 1.36 
(s, 3H), 1.29 (dtd, J = 9.3, 8.1, 4.6 Hz, 1H), 1.19 (d, J = 6.4 Hz, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.90 (d, J = 
6.9 Hz, 3H), 0.88 (s, 9H), 0.65 –0.56 (m, 6H), 0.09 (s, 3H), 0.08 ppm (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 166.6, 154.6, 119.4, 80.8, 79.2, 78.9, 75.7, 75.0, 74.1, 63.2, 38.6, 36.7, 33.5, 31.8, 28.2, 26.0, 18.4, 
16.7, 16.3, 14.5, 7.2, 6.8, 3.64, 3.60, 4.4, 4.9 ppm. IR (film): ?̃? = 2955, 2932, 2120, 1717, 1655, 
1459, 1362, 1254, 1159, 1082, 1004, 836, 776, 724 cm-1. HR-ESI: m/z calcd. for [C32H58O4Si2Na]
+: 
585.37601, found 585.37659.  
(5R,8S,13S,14R,E)-8-((tert-Butyldimethylsilyl)oxy)-5,13,14-trimethyl-5-((triethylsilyl)-oxy)oxacyclo-
tetradec-3-en-9-yn-2-one (14). Diyne 13 (800 mg, 1.42 mmol) was added to a suspension of 
molecular sieves 5 Å (flame dried, 6 g) in toluene (750 mL) at room temperature and the resulting 
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mixture was stirred for 1 hour. [(Ph3SiO)4MoCPh]K (21) (188 mg, 0.142 mmol, 10 
mol%) was then added in one portion and stirring continued for 2 h. The suspension 
was filtered through a plug of Celite®, which was carefully rinsed with EtOAc. The 
combined filtrates were concentrated and the residue was purified by flash 
chromatography (silica, hexanes/EtOAc, 30:1 to 20:1) to furnish the title compound 
as a colorless oil (672 mg, 92%). 1H NMR (400 MHz, CDCl3) δ = 7.05 (d, J = 15.3 Hz, 1H), 5.97 (d, J = 
15.3 Hz, 1H), 4.68 (dq, J = 9.1, 6.3 Hz, 1H), 4.34 (dq, J = 8.4, 2.1 Hz, 1H), 2.27 (dddd, J = 17.0, 7.0, 5.2, 
1.9 Hz, 1H), 2.15 (dddd, J = 17.0, 8.6, 5.2, 2.0 Hz, 1H), 1.95 – 1.76 (m, 2H), 1.66 (dtd, J = 9.1, 6.8, 3.8 
Hz, 1H), 1.62 – 1.54 (m, 2H), 1.54 – 1.35 (m, 2H), 1.32 (s, 3H), 1.27 (d, J = 6.3 Hz, 3H), 0.96 (t, J = 7.9 
Hz, 9H), 0.90 (d, J = 6.9 Hz, 3H), 0.87 (s, 9H), 0.65 –0.57 (m, 6H), 0.08 (s, 3H), 0.07 ppm (s, 3H). 13C 
NMR (101 MHz, CDCl3) δ = 166.6, 155.1, 119.0, 85.4, 81.5, 75.5, 74.9, 63.4, 39.2, 37.6, 33.3, 32.9, 
27.5, 25.9, 19.2, 18.3, 17.0, 16.9, 7.2, 6.9, 4.3, 4.8 ppm. IR (film): ?̃? = 2955, 2932, 2877, 1715, 1459, 
1342, 1251, 1162, 1106, 1081, 1048, 1005, 976, 836, 777, 724 cm-1. HR-ESI: m/z calcd. for 
[C28H52O4Si2Na]
+: 531.32927, found 531.32964.  
(5R,8S,13S,14R,E)-5,8-Dihydroxy-5,13,14-trimethyloxacyclotetradec-3-en-9-yn-2-one (15). 
HF/pyridine (70% in pyridine, 372 µL, 2.89 mmol) was added dropwise to a solution of 
compound 14 (545 mg, 0.96 mmol) and pyridine (702 µL, 8.7 mmol) in THF (7 mL). The 
mixture was stirred for 5 h before additional HF/pyridine (124 µL, 0.96 mmol) was 
introduced. Stirring was continued for another 12 h before the reaction was quenched 
with sat. aq. NaHCO3. After extraction of the aqueous layer with EtOAc, the combined 
extracts were washed with brine and dried over MgSO4, the drying agent was filtered off and the 
solvent was evaporated. Purification of the residue by flash chromatography (silica, hexanes/EtOAc, 
1:1) afforded the title compound as a white crystalline solid (365 mg, 84%). Mp = 150 – 152 °C. [𝑎]𝐷
20: 
‒50.2 (c = 1, CH3OH). 
1H NMR (400 MHz, CDCl3) δ = 7.17 (d, J = 15.6 Hz, 1H), 6.02 (d, J = 15.6 Hz, 1H), 
4.69 (dq, J = 12.5, 6.5 Hz, 1H), 4.50 – 4.37 (m, 1H), 2.39 – 2.25 (m, 1H), 2.25 – 2.13 (m, 1H), 1.87 (m, 
3H), 1.80 – 1.66 (m, 4H), 1.48 (p, J = 6.3, 5.6 Hz, 2H), 1.34 (s, 3H), 1.29 (d, J = 6.3 Hz, 3H), 0.92 ppm (d, 
J = 7.0 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 166.2, 154.2, 119.1, 87.2, 80.6, 75.2, 73.3, 62.7, 39.1, 
36.9, 32.9, 31.8, 27.3, 19.1, 17.04, 16.96 ppm. IR (film) ?̃? = 3402, 2972, 2934, 1698, 1455, 1379, 1339, 
1268, 1102, 1036, 977 cm-1. HR-ESI: m/z calcd. for [C16H24O4Na]
+: 303.15665, found 303.15668.  
(3E,5R,8S,9Z,13S,14R)-5,8-Dihydroxy-5,13,14-trimethyl-9-(tributylstannyl) oxacyclotetradeca-3,9-
dien-2-one (16). Tributyltin hydride (0.37 mL, 1.38 mmol) was added dropwise 
over 5 min to a stirred solution of alkyne 15 (336 mg, 1.2 mmol) and [{Cp*RuCl2}n] 
(18 mg, 5 mol%) in CH2Cl2 (15 mL, 0.08 M). The resulting mixture was stirred for 
15 min before all volatile materials were evaporated. Purification of the residue 
by flash chromatography (hexanes/EtOAc, 3:1) afforded the title compound as a 
pale yellow oil that solidified upon standing (587 mg, 83%). [𝑎]𝐷
20: ‒41.2 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 6.91 (d, J = 15.6 Hz, 1H), 6.36 (dd, J = 9.2, 5.2, JSn–H = 121.7 Hz, 1H), 5.99 (d, J = 15.6 
Hz, 1H), 4.58 (dq, J = 10.2, 6.3 Hz, 1H), 4.28 –4.04 (m, 1H), 2.09 – 1.93 (m, 2H), 1.89 – 1.80 (m, 1H), 
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1.80 – 1.66 (m, 3H), 1.56 –1.39 (m, 8H), 1.36 (s, 3H), 1.36 – 1.16 (m, 12H), 1.02 – 0.82 ppm (m, 18H). 
13C NMR (101 MHz, CDCl3): δ = 166.0, 153.5, 146.4, 143.0, 119.7, 83.2, 76.3, 73.9, 39.8, 38.3, 34.4, 
32.6, 31.5, 29.4, 28.1, 27.5, 19.0, 17.7, 13.8, 11.2 ppm. 119Sn NMR (186 MHz, CDCl3) δ = 54.9 ppm. IR 
(film): ?̃? = 3450, 2954, 2924, 2871, 2853, 1698, 1640, 1455, 1377, 1281, 1267, 1153, 1133, 1104, 
1044 cm-1. HR-ESI: calcd. for [C28H52O4SnNa]
+: 595.27791, found 595.27750.  
(–)-5,6-Dihydrocineromycin B (3). [Pd(PPh3)4] (29 mg, 0.025 mmol, 5 mol%) was added to a solution 
of compound 16 (285.7 mg, 0.50 mmol) and flame-dried [Ph2PO2][NBu4] (253 mg, 
0.55 mmol) in DMF (2.5 mL). The resulting mixture was stirred for 5 min before CuTC 
(100 mg, 0.53 mmol) was introduced, followed by MeI (0.75 mmol, 47 µL) 30 seconds 
later.3 The resulting mixture was stirred for 30 min before it was diluted with Et2O 
and the reaction was quenched with water. The aqueous layer was extracted with 
Et2O, the combined extracts were dried over MgSO4, the drying agent was filtered off and the 
solution was concentrated. Purification of the residue by flash chromatography (hexanes/EtOAc, 1:1) 
afforded the title compound as a white solid (137 mg, 92%). [𝑎]𝐷
20: ‒86.9 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): see Table S-1; 
13C NMR (101 MHz, CDCl3): see Table S-2. IR (film): ?̃? = 3401, 2971, 2935, 
2876, 1696, 1639, 1450, 1377, 1268, 1154, 1104, 1041, 985, 755 cm-1. HR-ESI: calcd. for [C17H28O4Na]
+ 
319.18798; found 319.18795. 
 
Table S-1. Comparison of the 
1
H NMR data (CDCl3, H in ppm) of 5,6-dihydrocineromycin B (3) prepared herein 
with the data reported in the literature; numbering scheme as shown in the Insert 
Position Isolation
4
 Zhai et al
5
 Current study 
2 5.98 (d, J = 15.5 Hz, 1H) 5.95 (d, J = 15.9 Hz, 1H) 5.95 (d, J = 15.6 Hz, 1H) 
3 6.82 (d, J = 15.5 Hz, 1H) 6.84 (d, J = 15.6 Hz, 1H) 6.84 (d, J = 15.6 Hz, 1H) 
4    
5 1.95 (m, 2H) 1.89 – 1.75 (m, 1H) 
1.61 – 1.57 (m, 1H) 
1.89 – 1.76 (m, 1H) 
1.63 – 1.55 (m, 1H) 
6 1.81 (m, 1H) 
1.57 (m, 1H) 
1.73 – 1.67 (m, 2H) 1.73 – 1.67 (m, 2H) 
7 3.97 (dd, J = 15.5, 1.5 Hz, 1H) 3.98 (t, J = 6.0 Hz, 1H) 3.98 (t, J = 6.1 Hz, 1H) 
9 5.49 (m, 1H) 5.51 (dd, J = 9.9, 2.7 Hz, 1H) 5.50 (ddd, J = 10.4, 3.7, 1.7 Hz, 1H) 
10 2.09 (m, 1H) 
1.80 (m, 1H) 
2.16 – 2.02 (m, 1H) 
1.89 – 1.75 (m, 1H) 
2.11 (ddt, J = 15.0, 10.0, 5.0 Hz, 1H) 
1.89 – 1.76 (m, 1H) 
11 1.30 – 1.25 (m, 2H) 1.45 – 1.37 (m, 1H) 
1.32 – 1.25 (m, 1H) 
1.47 – 1.38 (m, 1H) 
1.34 – 1.25 (m, 1H) 
12 1.39 (m, 1H) 1.89 – 1.75 (m, 1H) 1.89 – 1.76 (m, 1H) 
13 4.55 (m, 1H) 4.60 – 4.51 (m, 1H) 4.56 (dq, J = 10.1, 6.2 Hz, 1H) 
4-CH3 1.34 (s, 3H) 1.35 (s, 3H) 1.35 (s, 3H) 
8-CH3 1.51 (d, J = 0.5 Hz, 3H) 1.54 (s, 3H) 1.53 (t, J = 1.3 Hz, 3H) 
12-CH3 0.92 (d, J = 7.0 Hz, 3H) 0.94 (d, J = 6.9 Hz, 3H) 0.94 (d, J = 6.9 Hz, 3H) 
13-CH3 1.30 (m, 3H) 1.30 (d, J = 6.3 Hz, 3H) 1.29 (d, J = 6.2 Hz, 3H) 
                                                          
3
  The order of addition and the timing are important. 
4
  H. J. Schiewe, A. Zeeck J. Antibiot. 1999, 52, 635-642. 
5




Table S-2. Comparison of the 
13
C NMR data (CDCl3, C in ppm) of 3 prepared herein with the data reported in 
the literature; numbering scheme as shown in the Insert 
Position Isolation
4
 Zhai et al.
5
 Current study 
1 166.1 166.1 166.2 
2 118.9 118.9 119.1 
3 153.8 153.8 153.9 
4 73.1 73.1 73.3 
5 39.0 39.0 39.2 
6 29.7 29.3 29.5 
7 79.6 79.6 79.9 
8 135.2 135.2 135.3 
9 128.8 128.8 129.1 
10 23.8 23.8 24.0 
11 33.2 33.2 33.4 
12 38.1 38.1 38.3 
13 75.5 75.5 75.7 
4-CH3 28.2 28.2 28.4 
8-CH3 11.1 11.1 11.2 
12-CH3 17.2 17.2 17.4 
13-CH3 19.0 19.0 19.2 
 
(3E,5R,8S,9E,13S,14R)-5,8-Dihydroxy-5,13,14-trimethyloxacyclotetradeca-3,9-dien-2-one (17). 
Compound 16 (15 mg, 0.026 mmol) and CuTC (6 mg, 0.032 mmol) were added to a 
solution of [Ph2PO2][NBu4] (13.3 mg, 0.029 mmol) in DMF (0.15 mL). The mixture was 
stirred for 1 h before it was diluted with Et2O and the reaction was quenched with 
water. The aqueous layer was extracted with Et2O, the combined extracts were dried 
over MgSO4, the drying agent was filtered off, and the solution was concentrated. 
Purification of the residue by flash chromatography (hexanes/EtOAc, 1:1) afforded the title 
compound as a colorless oil (6 mg, 78%). [𝑎]𝐷
20: ‒93.5 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 
6.79 (d, J = 15.7 Hz, 1H), 5.95 (d, J = 15.7 Hz, 1H), 5.68 (dddd, J = 15.4, 9.1, 4.4, 0.8 Hz, 1H), 5.29 
(dddd, J = 15.4, 8.1, 1.7, 1.0 Hz, 1H), 4.60 (dq, J = 10.1, 6.2 Hz, 1H), 4.01 (td, J = 8.4, 3.4 Hz, 1H), 2.11 – 
1.98 (m, 1H), 1.95 –1.83 (m, 2H), 1.81 – 1.63 (m, 3H), 1.60 – 1.56 (bs, 1H), 1.52 – 1.41 (m, 3H), 1.34 (s, 
3H), 1.30 (d, J = 6.1 Hz, 3H), 1.27 – 1.23 (bs, 1H), 0.93 ppm (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ = 166.1, 154.1, 133.12, 133.05, 119.2, 74.9, 73.6, 73.3, 38.5, 36.7, 32.5, 30.7, 28.3, 27.9, 
19.3, 16.8 ppm. IR (film) ?̃? = 3398, 2962, 2931, 2874, 1697, 1642, 1453, 1377, 1261, 1161, 1101, 
1043, 967 cm-1. HR-ESI: calcd. for [C16H26O4Na]
+ 305.17233; found 305.17241. 
(3E,5R,8S,9Z,13S,14R)-5,8-Dihydroxy-5,13,14-trimethyloxacyclotetradeca-3,9-dien-2-one (18). 
Hydrogen gas was bubbled through a suspension of Pd/BaSO4 (5% on BaSO4, 0.76 mg) 
in pyridine (1 mL) until the suspension turned black. A solution of alkyne 15 (20 mg, 71 
µmol) in THF (1 mL) was introduced and the mixture was stirred for 3 h under 
hydrogen atmosphere. The suspension was filtered through a plug of Celite®, the 
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filtrate was concentrated and the residue purified by flash chromatography (silica, hexanes/EtOAc, 
1:1) to furnish the title compound as a colorless foam (15 mg, 74%); the product contained ca. 5% of 
overreduced product formed by saturation of the former triple bond. [𝑎]𝐷
20: 31.1 (c = 1, CHCl3). 
1H 
NMR (400 MHz, CDCl3): δ = 6.89 (d, J = 15.7 Hz, 1H), 6.03 (dd, J = 15.7, 1.4 Hz, 1H), 5.48 (tdd, J = 10.0, 
5.6, 0.9 Hz, 1H), 5.37 (ddt, J = 10.8, 9.0, 1.1 Hz, 1H), 4.65 (dq, J = 9.9, 6.3 Hz, 1H), 4.31 (tt, J = 9.3, 1.6 
Hz, 1H), 2.20 – 2.08 (m, 1H), 2.04 –1.90 (m, 2H), 1.84 – 1.75 (m, 1H), 1.60 – 1.44 (m, 2H), 1.40 (s, 3H), 
1.38 – 1.31 (m, 1H), 1.29 (d, J = 6.3 Hz, 3H), 1.27 – 1.21 (m, 2H), 1.21 – 1.04 (m, 2H), 0.93 ppm (d, J = 
6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 166.0, 153.0, 133.1, 131.2, 120.8, 76.2, 74.0, 69.7, 41.1, 
39.1, 35.0, 31.6, 29.0, 27.8, 19.3, 17.2 ppm. IR (film): ?̃? = 3402, 2925, 1694, 1454, 1378, 1260, 1043, 
730 cm-1. HR-ESI: calcd. for [C16H26O4Na]
+ 305.17233; found 305.17227.  
(3E,5R,8S,9Z,13S,14R)-9-Chloro-5,8-dihydroxy-5,13,14-trimethyloxacyclotetradeca-3,9-dien-2-one 
(19). Copper(II)chloride (25 mg, 0.19 mmol) was added in one portion to a solution 
of stannane 16 (42 mg, 0.07 mmol) in THF (0.35 mL) and the resulting mixture was 
stirred for 23 h. The reaction was quenched with water and the aqueous layer 
extracted with CH2Cl2. The combined extracts were washed with brine and dried 
over MgSO4, the drying agent was filtered off, and the solvent was evaporated. 
Purification of the residue by flash chromatography (silica, hexanes/EtOAc, 2:1) afforded the title 
compound as a colorless oil (18 mg, 77%). [𝑎]𝐷
20: ‒24.3 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 
6.76 (d, J = 15.7 Hz, 1H), 5.98 (d, J = 15.4 Hz, 1H), 5.84 (dd, J = 9.3, 4.0 Hz, 1H), 4.56 (dq, J = 10.1, 6.2 
Hz, 1H), 4.15 – 4.08 (m, 1H), 2.39 –2.28 (m, 1H), 2.05 – 1.87 (m, 4H), 1.82 – 1.69 (m, 3H), 1.59 – 1.49 
(m, 2H), 1.48 –1.40 (m, 1H), 1.36 (s, 3H), 1.31 (d, J = 6.6 Hz, 3H), 0.95 ppm (d, J = 7.1 Hz, 3H). 13C NMR 
(101 MHz, CDCl3): δ = 165.9, 153.1, 135.0, 129.3, 119.7, 76.7, 75.5, 73.0, 38.5, 38.4, 32.2, 29.5, 28.7, 
24.6, 19.2, 17.3 ppm. IR (film) ?̃? = 3401, 2964, 2932, 2875, 1696, 1451, 1378, 1263, 1160, 1101, 1044 
cm-1. HR-ESI: calcd. for [C16H25O4ClNa]
+ 339.13344; found 339.13336.  
(1S,5R,6S,11S,14R)-11-Hydroxy-5,6,14-trimethyl-4,15-dioxabicyclo[12.1.0]pentadec-9-yn-3-one 
(20). TBAF (1 M in THF, 750 µL, 0.75 mmol) was added dropwise to a solution of 
compound 14 (127 mg, 0.25 mmol) in THF (10 mL) and the resulting mixture was 
stirred for 4 h at room temperature. Additional TBAF (1 M in THF, 750 µL, 0.75 mmol) 
was introduced and stirring continued for another 12 h. The reaction was quenched 
with water and the aqueous layer extracted with tert-butyl methyl ether. The 
combined extracts were washed with brine and dried over MgSO4, the drying agent was filtered off 
and the solvent was evaporated. Purification of the residue by flash chromatography (silica, 
hexanes/EtOAc, 6:1 to 1:1) afforded the title compound as a white crystalline solid (68 mg, 97%). Mp 
= 101-102 °C. [𝑎]𝐷
20: +57.3 (c = 1, CH3OH). 
1H NMR (400 MHz, CDCl3) δ = 4.79 – 4.69 (m, 2H), 4.59 (dd, 
J = 11.3, 2.0 Hz, 1H), 2.58 (dd, J = 14.1, 2.0 Hz, 1H), 2.54 (s, 1H), 2.34 (dd, J = 14.1, 11.3 Hz, 1H), 2.23 
(ddt, J = 7.8, 5.3, 2.6 Hz, 2H), 2.12 – 1.89 (m, 3H), 1.86 – 1.73 (m, 2H), 1.69 –1.58 (m, 1H), 1.53 (dddd, 
J = 14.0, 4.9, 2.4, 1.2 Hz, 1H), 1.28 (d, J = 6.3 Hz, 3H), 1.17 (s, 3H), 1.05 ppm (d, J = 7.2 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ = 171.2, 90.4, 79.7, 75.3, 75.2, 68.5, 66.2, 37.5, 36.1, 34.3, 29.7, 25.7, 24.3, 
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19.1, 16.3, 15.0 ppm. IR (film) ?̃? = 3468, 2933, 1731, 1449, 1380, 1286, 1247, 1155, 1101, 1061, 1001, 
958 cm-1. HR-ESI: m/z calcd. for [C16H24O4Na]
+: 303.15668; found 303.15668. 
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